SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : RNAi -- Ignore unavailable to you. Want to Upgrade?


To: michael_f_murphy who wrote (89)9/11/2003 3:47:03 PM
From: tuck  Read Replies (1) | Respond to of 671
 
>>Nucleonics
Malvern, Pa.
Private
Robert Towarnicki, president & CEO; C.
Satishchandran, vice president of R&D; Cathy
Pachuk, senior director of biological research
Developing RNAi-based drugs for
hepatitis B and C.<<

Caveat emptor; these are the folks who bought you Cell Pathways (CLPA).

Cheers, Tuck